
Santrax SB 250mg/125mg Injection
Marketer
Ultratech Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Santrax SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance; adhere to the prescribed dosage schedule. Complete the full treatment course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician about all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration promote faster recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Santrax SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Santrax SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Santrax SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Santrax SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Santrax SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Santrax SB 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a powerful antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this action by neutralizing enzymes that bacteria use to resist antibiotic effects, thus bolstering Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Santrax SB 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
Administration of Santrax SB 250mg/125mg Injection during gestation is typically deemed safe. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; however, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Santrax SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Santrax SB 250mg/125mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Santrax SB 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Santrax SB 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Santrax SB 250mg/125mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Santrax SB 250mg/125mg Injection :
Omit a Santrax SB 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Santrax SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
